Surgery Versus Pharmacological Treatment for Endometriosis

Sarit Avraham, Daniel S Seidman
Women's health (London, England) · 2014 · vol. 10(2) , pp. 161–166 · doi:10.2217/whe.13.77 · PMID:24601807 · W2100978254
article OA: gold CC0 ⤵ 5 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This review discusses the ongoing debate regarding surgical versus pharmacological treatment for endometriosis-related pain and infertility, emphasizing individualized treatment based on indication and patient factors.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The two major consequences of endometriosis are pain and infertility. Despite numerous studies and proposed guidelines, some aspects of the treatment for these complications are still under debate or lack convincing evidence that favors one approach over the other. Future studies will hopefully present new evidence in regard to the optimal treatment for each indication and suggest innovative pharmacotherapy following improved understanding of the pathophysiology of endometriosis. Until then, individualization of the treatment according to the specific indication, taking into consideration the benefits versus the risks for the patient and the tolerability profile, remains the most appropriate approach.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_paininfertility

MeSH descriptors

Anti-Inflammatory Agents, Non-Steroidal Contraceptives, Oral, Combined Endometriosis Fertilization in Vitro Gonadotropin-Releasing Hormone Gynecologic Surgical Procedures Infertility, Female Pelvic Pain Progestins Anti-Inflammatory Agents, Non-Steroidal Contraceptives, Oral, Combined Endometriosis Endometriosis Female Fertilization in Vitro Gonadotropin-Releasing Hormone Gynecologic Surgical Procedures Humans Infertility, Female Infertility, Female

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (51)

Cited by (5)

Source provenance

europepmc
last seen: 2026-06-20T06:14:18.781669+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:35.150238+00:00
License: CC0 · commercial use OK